Skip to main content
SpringerLink
Log in

Current Medical Treatments for Uterine Fibroids

  • Chapter
  • First Online:
Book cover Uterine Fibroids and Adenomyosis

Part of the book series: Comprehensive Gynecology and Obstetrics ((CGO))

  • 762 Accesses

Abstract

Uterine fibroids are benign tumors with a high prevalence rate and are considered the most common benign tumors in women of reproductive age. Surgical or medical treatment is necessary when symptoms, such as abnormal uterine bleeding, pelvic pain, and infertility, occur. Regarding hormonal therapies, a large number of GnRH agonist therapies have been employed. Current alternative treatments for the improvement of abnormal uterine bleeding and reduction of fibroid volume include GnRH antagonists, aromatase inhibitors, progestin, and selective progesterone receptor modulators, and their therapeutic effects have been studied.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Laughlin SK, et al. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010;28:204–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Stewart EA. Uterine fibroids. Lancet. 2001;357:293–8.

    Article  CAS  PubMed  Google Scholar 

  3. Buttram JVC, et al. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433.

    Article  PubMed  Google Scholar 

  4. Manyonda IT, et al. Uterine artery embolization versus myomectomy: impact on quality of life-results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovasc Intervent Radiol. 2012;35:530–6.

    Article  PubMed  Google Scholar 

  5. Stewart EA, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85:22–9.

    Article  PubMed  Google Scholar 

  6. Ishikawa H, et al. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151:2433–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Taylor DK, et al. Treatment for uterine fibroids: searching for effective drug therapies. Drug Discov Today Ther Strateg. 2012;9:e41–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chang WC, et al. Comparison of laparoscopic myomectomy in large myomas with and without leuprolide acetate. J Minim Invasive Gynecol. 2015;22:992–6.

    Article  PubMed  Google Scholar 

  9. Muzii L, et al. GnRH analogue treatment before hysteroscopic resection of submucosal myomas: a prospective, randomized, multicenter study. Fertil Steril. 2010;94:1496–9.

    Article  CAS  PubMed  Google Scholar 

  10. Lethaby A, et al. Preoperative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;2:CD000547.

    Google Scholar 

  11. Fernandez H, et al. One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial. Hum Reprod. 2004;19:1465–1.

    Article  CAS  PubMed  Google Scholar 

  12. Felberbaum RE, et al. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. Hum Reprod. 1998;13:1660–8.

    Article  CAS  PubMed  Google Scholar 

  13. Kettel LM, et al. Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril. 1993;60:642–6.

    Article  CAS  PubMed  Google Scholar 

  14. Engel JB, et al. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study. Eur J Obstet Gynecol Reprod Biol. 2007;134:225–32.

    Article  CAS  PubMed  Google Scholar 

  15. Gonzalez-Barcena D, et al. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix. Hum Reprod. 1997;12:2028–35.

    Article  CAS  PubMed  Google Scholar 

  16. Dohan N, et al. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal woman. Eur J Obstet Gynecol Reprod Biol. 2013;171:329–32.

    Article  CAS  Google Scholar 

  17. Parsanezhad ME, et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril. 2010;93:192–8.

    Article  CAS  PubMed  Google Scholar 

  18. Song H, et al. Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev. 2013;(10):CD009505.

    Google Scholar 

  19. Kriplani A, et al. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma. Int J Gynaecol Obstet. 2012;116:35–8.

    Article  CAS  PubMed  Google Scholar 

  20. Sayed GH, et al. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int J Gynaecol Obstet. 2011;112:126–30.

    Article  CAS  PubMed  Google Scholar 

  21. Magalhães J, et al. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception. 2007;75:193–8.

    Article  CAS  PubMed  Google Scholar 

  22. Marui T, et al. Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. Contraception. 2007;75:S99–103.

    Article  CAS  Google Scholar 

  23. Catherino WH, et al. Novel, orally active selective progesterone receptor modulator CB8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium. J Steroid Biochem Mol Biol. 2010;122:279–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Mutter GL, et al. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol. 2008;21:591–8.

    Article  CAS  PubMed  Google Scholar 

  25. Murphy AA, et al. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab. 1993;76:513–7.

    PubMed  CAS  Google Scholar 

  26. Kulshrestha V, et al. Low dose mifepristone in medical management of uterine leiomyoma—an experience from a tertiary care hospital from north India. Indian J Med Res. 2013;137:1154–2.

    PubMed  PubMed Central  CAS  Google Scholar 

  27. Esteve JL, et al. Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial. Int J Women’s Health. 2013;5:361–9.

    Article  CAS  Google Scholar 

  28. Tristan M, et al. Mifepristone for uterine fibroids. Cochrane Database Syst Rev. 2012;8:CD007687.

    Google Scholar 

  29. Biglia N, et al. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther. 2014;8:285–92.

    PubMed  PubMed Central  CAS  Google Scholar 

  30. Talaulikar VS, et al. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Devel Ther. 2012;29:655–63.

    Article  Google Scholar 

  31. Fiscella K, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol. 2008;112:707.

    Article  PubMed  Google Scholar 

  32. Nieman LK, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blinded, placebo-controlled, phase IIb study. Fertil Steril. 2011;95:767–2e1–2.

    Article  CAS  PubMed  Google Scholar 

  33. Donnez J, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409–20.

    Article  CAS  PubMed  Google Scholar 

  34. Donnez J, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366:421–32.

    Article  CAS  PubMed  Google Scholar 

  35. Donnez J, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101:1565–73.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

    Izumi Kusuki M.D., Ph.D. & Jo Kitawaki M.D., Ph.D.

Authors
  1. Izumi Kusuki M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jo Kitawaki M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Izumi Kusuki M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan

    Norihiro Sugino

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kusuki, I., Kitawaki, J. (2018). Current Medical Treatments for Uterine Fibroids. In: Sugino, N. (eds) Uterine Fibroids and Adenomyosis. Comprehensive Gynecology and Obstetrics. Springer, Singapore. https://doi.org/10.1007/978-981-10-7167-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7167-6_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7166-9

  • Online ISBN: 978-981-10-7167-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation